MedTrace Logo

Middle Meatal Bacteriology During Acute Respiratory Infection in Children

NCT00545961 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2007-10-19

No results posted yet for this study

Summary

The purpose of this study is to find out whether the children with respiratory infection and the presence of pathogenic bacteria (S. pneumoniae, H. influenzae or M. catarrhalis) in the nasal middle meatus benefit from antimicrobial treatment.

Conditions

  • Acute Respiratory Infection
  • Sinusitis

Interventions

DRUG

placebo

mixture, 0.28125 ml/kg twice a day for 7 days

DRUG

amoxicillin clavulanate acid

mixture 0.28125 ml / kg twice a day for 7 days

Sponsors & Collaborators

  • Oulu University Hospital

    lead OTHER

Principal Investigators

  • Jukka-Pekka Kuusiniemi, MD · Dept of Otolaryngology, Seinäjoki Central Hospital, Finland

  • Eeva Löfgren, MD · Dept of Otolaryngology, Kokkola Central Hospital, Finland

  • Anna Marttila, MD · Dept of Otolaryngology, University of Oulu, Finland

  • Olli-Pekka Alho, professor · Dept of Otolaryngology, University of Oulu, Finland

  • Aila Kristo, MD · Dept of Otolaryngology, University of Oulu, Finland

  • Ulla Lantto, MD · Dept of Otolaryngology, University of Oulu, Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
13 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-11-30
Completion
2009-12-31

Countries

  • Finland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00545961 on ClinicalTrials.gov